Item 8.01 July 24, 2015 GS


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 24, 2015
 
Accretive Health, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Delaware
 
001-34746
 
02-0698101
(State or Other Jurisdiction
of Incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
401 North Michigan Avenue, Suite 2700, Chicago, Illinois
 
60611
(Address of Principal Executive Offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (312) 324-7820
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))










1



Item 8.01. Other Events

On July 24, 2015, Accretive Health, Inc. announced that its Board of Directors has retained Goldman, Sachs & Co., to serve as financial advisor to the Company and to assist the Board in its evaluation of potential strategic alternatives.  A copy of the press release is attached as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

Exhibits



2


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
ACCRETIVE HEALTH, INC.
 
 
 
 
Date: July 24, 2015
 
 
By:
 
/s/ Peter P. Csapo
 
 
 
 
 
Name: Peter P. Csapo
 
 
 
 
 
Title: Chief Financial Officer and Treasurer


3


EXHIBIT INDEX


Exhibit Number        Description of Exhibit

99.1            Press release issued by Accretive Health, Inc. dated July 24, 2015



4